Oral hairy leukoplakia in the buccal mucosa of a healthy, HIV-negative patient

Gülhan Gürel; Sevinç Şahin; Betül Aytekin; Emine Çölgecen

doi:10.28982/josam.412354

Authors

Gülhan Gürel https://orcid.org/0000-0001-5716-8750
Sevinç Şahin
Betül Aytekin
Emine Çölgecen

DOI:

https://doi.org/10.28982/josam.412354

Keywords:

Oral hairy leukoplakia, HIV-negative patient, Buccal mucosa

Abstract

Oral hairy leukoplakia (OHL), first described in 1984, is an Epstein-Barr virus lesion located laterally in the tongue and manifesting as a white, asymptomatic mucosal plaque which cannot be removed by scraping. OHL is more commonly observed in HIV-positive patients, in immunosuppressed patients after kidney, heart, liver and bone marrow transplantation, in hematological malignancies such as multiple myeloma, and in patients undergoing systemic or topical steroid therapy. OHL has rarely been reported in healthy patients who are not immunosuppressive. The case of an otherwise healthy, HIV-negative 24 year-old woman with OHL lesions in the buccal mucosa is presented here because of its rarity.

Downloads

Download data is not yet available.

References

Greenspan D, Greenspan JS, Conant M, et al. Oral “hairy” leukoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet. 1984;2:831-4.

Piperi E, Omlie J, Koutlas IG, Pambuccian S. Oral hairy leukoplakia in HIV-negative patients: report of 10 cases. Int J Surg Pathol. 2010;18:177-83.

Bravo IM, Correnti M, Escalona L, et al. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med Oral Patol Oral Cir Bucal. 2006;11:E33-E39.

Prasad JL, Bilodeau EA. Oral hairy leukoplakia in patients without HIV: presentation of 2 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:e151-60.

Felix DH, Watret K, Wray D, Southam JC. Hairy leukoplakia in an HIV-negative, nonimmunosuppressed patient. Oral Surg Oral Med Oral Pathol. 1992;74:563-6.

Ficarra G, Romagnoli P, Piluso S, et al. Hairy leukoplakia with involvement of the buccal mucosa. J Am Acad Dermatol. 1992;27:855-8.

Hall LD, Eminger LA, Hesterman KS, Heymann WR. Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders. J Am Acad Dermatol. 2015;72:1-19.

Scully C, Porter SR, Di Alberti L, et al. Detection of Epstein-Barr virus in oral scrapes in HIV-infection, in hairy leukoplakia, and in healthy non-HIV-infected people. J Oral Pathol Med. 1998;27:480-2.

Walling DM, Flaitz CM, Nichols CM. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir. J Infect Dis. 2003;188:883-90.

Moura MD, Guimar~aes TR, Fonseca LM, et al. A random clinical trial study to assess the efficiency of topical applications of podophyllin resin (25%) versus podophyllin resin (25%) together with acyclovir cream (5%) in the treatment of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:64-71.

Schöfer H, Ochsendorf FR, Helm EB, Milbradt R. Treatment of oral ‘hairy’ leukoplakia in AIDS patients with vitamin A acid (topically) or acyclovir (systemically). Dermatologica. 1987;174:150-1.

Bhandarkar SS, MacKelfresh J, Fried L, Arbiser JL. Targeted therapy of oral hairy leukoplakia with gentian violet. J Am Acad Dermatol. 2008;58:711-2.

Goh BT, Lau RK. Treatment of AIDS-associated oral hairy leukoplakia with cryotherapy. Int J STD AIDS. 1994;5:60-2.